Evaluation of the Drug–Drug Interaction Potential of Acalabrutinib and Its Active Metabolite,
ACP
‐5862, Using a
Physiologically‐Based Pharmacokinetic
Modeling Approach
2019 ◽
Vol 8
(7)
◽
pp. 489-499
◽
Diansong Zhou
◽
Terry Podoll
◽
Yan Xu
◽
Ganesh Moorthy
◽
Karthick Vishwanathan
◽
...
2016 ◽
Vol 55
(11)
◽
pp. 1435-1445
◽
Nageshwar R. Budha
◽
Tao Ji
◽
Luna Musib
◽
Steve Eppler
◽
Mark Dresser
◽
...
2016 ◽
Vol 5
(5)
◽
pp. 250-257
◽
D Zhou
◽
K Bui
◽
M Sostek
◽
N Al‐Huniti
Stefan Willmann
◽
Katrin Coboeken
◽
Stefanie Kapsa
◽
Kirstin Thelen
◽
Markus Mundhenke
◽
...
Maxime Le Merdy
◽
Ming-Liang Tan
◽
Dajun Sun
◽
Zhanglin Ni
◽
Sue-Chih Lee
◽
...
2017 ◽
Vol 40
(12)
◽
pp. 1356-1379
◽
Jee Sun Min
◽
Soo Kyung Bae
2014 ◽
Vol 35
(9)
◽
pp. 543-552
◽
Chuang Lu
◽
Ajit Suri
◽
Wen Chyi Shyu
◽
Shimoga Prakash
Su-jin Rhee
◽
Hyun A. Lee
◽
Soyoung Lee
◽
Eunwoo Kim
◽
Inseung Jeon
◽
...
2014 ◽
Vol 63
◽
pp. 103-112
◽
Binfeng Xia
◽
Avantika Barve
◽
Tycho Heimbach
◽
Tao Zhang
◽
Helen Gu
◽
...
2012 ◽
Vol 33
(2)
◽
pp. 111-121
◽
Vikash Kumar Sinha
◽
Jan Snoeys
◽
Nancy Van Osselaer
◽
Achiel Van Peer
◽
Claire Mackie
◽
...
2018 ◽
Vol 33
(1)
◽
pp. S48-S49
Ernesto Callegari
◽
Jian Lin
◽
Susanna Tse
◽
Theunis C. Goosen
◽
Vaishali Sahasrabudhe
◽
...
Close
Export Citation Format
Close
Share Document
Close